SBI Cards Q4 Review: Analysts Say 'Buy' On Better Spends, Asset Quality; Stock Falls
Analysts reiterated their 'buy' calls on SBI Cards & Payment Services Ltd. after the fourth quarter, citing better asset quality, recovery in spends and a decline in credit costs.
The card issuer saw its profit jump by half over the preceding quarter and more than threefold year-on-year in the three months to March, beating estimates. Its margin also expanded and gross non-performing asset ratio fell.
SBI Cards and Payment Services Q4 FY22 (Consolidated, YoY)
Net profit up 231% at Rs 580.86 crore.
Revenue rose 23% at Rs 2,850.31 crore.
EBIT up 61.57% at Rs 880.80 crore.
EBIT margin 30.9% versus 14.18%.
Gross NPA at 2.22% vs 2.4% as of December.
Dividend per share: Rs 2.5
Brokerages also expect SBI Cards to be a key beneficiary of digital payment adoption.
Shares of SBI Cards fell more than 3% in intraday day before closing with losses of over 1%. Of the 25 analysts tracking the company, 24 suggest a 'buy' and one recommends a 'sell', according to Bloomberg data. The average of 12-month consensus price target implies an upside of 38.5%.
Here's what brokerages have to say about SBI Cards' Q4 FY22 results.
Maintains 'buy' with a target price of Rs 1,150 apiece.
25% YoY operating profit growth and 45% YoY decline in provisions aided 3.3x earnings growth in Q4.
It is entering FY23 with a solid balance sheet and positive intent.
NII growth is showing acceleration but still lags receivable growth.
Strong recovery in spends and healthy card additions supported interchange fee growth.
Headline NPA ratios are nearly back to pre-Covid levels.
Identifies weak growth in revolvers, impact of MDR regulations and competition as key issues that would take time to resolve.
SBI Cards would be key beneficiary of digital payment adoption and credit card business, which has an extremely attractive growth trajectory.
Likes SBI Cards for high market share, strength of its parent that lower acquisition costs and high-quality customers.
The focus would shift to fresh cards issued and spend growth in the upcoming period.
SBI Cards has scope of rerating, and along with solid earnings growth, makes it an attractive stock.
Nomura
Reiterates 'buy' with a target price of Rs 1,250, an implied return of 50.45%.
Lower credit cost drove PAT beat.
SBI Cards is entering a transitory phase, where revolver book will build up in FY23F.
Asset quality drags are completely behind.
Expects EPS CAGR of 37% over FY22-25F, with RoEs averaging 26-27% over FY23-25F and spends/loan growth at a 21% CAGR.
The current valuation is still at a 10.5% discount to Bajaj Finance for a significantly superior RoE profile.
Expects credit cost to undershoot on a lower revolver mix of 25-27% compared to pre-Covid level of 35%.
Motilal Oswal
Reiterates 'buy', cuts target price from Rs 1,120 to Rs 1,100, still an implied return of 33%.
Sharp decline in provisions aided the earnings beat in March quarter.
Expects the company to deliver 50% earnings CAGR over FY22-24 leading to RoA/RoE of 7.3%/30.6%.
Growth in spends remained robust despite the Omicron impact in January.
Expects spends to remain healthy as economic activity picks up.
Improving asset quality to continue to result in controlled credit costs.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.